Advertisement

Topics

Latest "Pharmaceutical Marketing Ltd" News Stories

17:58 EDT 21st October 2018 | BioPortfolio

Here are the most relevant search results for "Pharmaceutical Marketing Ltd" found in our extensive news archives from over 250 global news sources.

More Information about Pharmaceutical Marketing Ltd on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Pharmaceutical Marketing Ltd for you to read. Along with our medical data and news we also list Pharmaceutical Marketing Ltd Clinical Trials, which are updated daily. BioPortfolio also has a large database of Pharmaceutical Marketing Ltd Companies for you to search.

Showing "Pharmaceutical Marketing" News Articles 1–25 of 11,000+

Sunday 21st October 2018

Global and Asia Natural Tartaric Acid Market Status and Future Forecast 20132023 [Report Updated: 20082018] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPart 3:Asia Market by company, Type, Application RegionPart 410:Key Regions of Asia Market by Type, ApplicationPart 11:Company information, Sales, Cost, Margin etc.Part 12:ConclusionMarket Segment as fo...


Eisai Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryEisai Inc Eisai is a healthcare company, which focuses on the discovery, development and marketing of pharmaceutical products. The company's major products include Aricept for Alzheimer's treatment, Aciphex for acid reflux, Akynzeo for nausea and vomiting dring the course of cancer chemotherapy, Aloxi antinausea medication injection, Banzel for adjunctive treatment and Panretin for the trea...

Cytox Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13082018] Prices from USD $250

SummaryCytox Ltd Cytox is a prognostic and diagnostic service provider that develops neurodegenerative disorders services. The company offers development of tests to identify individuals at risk of cognitive decline, Alzheimer's disease and other dementias and its blood tests are used to predict that patients with MCI will develop Alzheimer's disease. Its biomarkers are based on the cell cycle hyp...


GuillainBarre Syndrome Pipeline Review, H2 2018 [Report Updated: 09102018] Prices from USD $2000

GuillainBarre Syndrome Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide GuillainBarre Syndrome Pipeline Review, H2 2018, provides an overview of the GuillainBarre Syndrome Central Nervous System pipeline landscape.GuillainBarre syndrome GBS is a disorder in which the body's immune system attacks part of the peripheral nervous syst...

Terumo BCT Inc Medical Equipment Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryTerumo BCT Inc Terumo BCT, a subsidiary of Terumo Corp, provides blood component, therapeutic apheresis and cellular technologies. The company's product portfolio include automated blood collection system, information system, data collection system, apheresis system, cell processor, cell separation system, pathogen reduction technology system, whole blood processing system, orbisac system, ...

Aurobindo Pharma Ltd AUROPHARMA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryAurobindo Pharma Ltd Aurobindo Pharma is a pharmaceutical company which develops, manufactures and exports formulations and active pharmaceutical ingredients API's. Its products portfolio includes active pharma ingredients, formulations, antibiotics, antiretrovirals, anti allergics, gastroenterologicals, antiDiabetics, HIVs, peptides, nutraceutical and aurozymes. It also offers contract res...

Solo-1 Phase III Trial Demonstrates Lynparza Maintenance Therapy Cut the Risk of Disease Progression or Death by 70% in Patients with Newly-Diagnosed, Advanced BRCA-Mutated Ovarian Cancer

60% of patients receiving LYNPARZA remained progression-free at three years compared to 27% on placebo following platinum-based chemotherapy LYNPARZA is the only PARP inhibitor to demonstrate an improvement in progression-free survival as 1st-line maintenance treatment for advanced ovarian cancer AstraZeneca and Merck & Co., Inc., K...

SOLO-1 Phase 3 Trial Demonstrates LYNPARZA® (olaparib) Maintenance Therapy Cut the Risk of Disease Progression or Death by 70 Percent in Patients with Newly-Diagnosed, Advanced BRCA-Mutated Ovarian Cancer

60 Percent of Patients Receiving LYNPARZA Remained Progression-Free at Three Years Compared to 27 Percent on Placebo Following Platinum-Based Chemotherapy LYNPARZA Is the Only PARP Inhibitor to Demonstrate an Improvement in Progression-Free Survival in First-Line Maintenance Treatment for Newly-Diagnosed, Advanced Ovarian Cancer AstraZe...

Teva To Establish North America Headquarters In Parsippany-Troy Hills

PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Limited (TEVA) said that it will establish its North America headquarters in Parsippany-Troy Hills, including more than 1,000 high-wage jobs ...

Hairy Cell Leukemia Pipeline Review, H2 2018 [Report Updated: 16102018] Prices from USD $2000

Hairy Cell Leukemia Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hairy Cell Leukemia Pipeline Review, H2 2018, provides an overview of the Hairy Cell Leukemia Oncology pipeline landscape.Hairy cell leukemia is a rare, slowgrowing cancer of the blood in which bone marrow makes too many B cells lymphocytes, a type of white blood...

Cataract Pipeline Review, H2 2018 [Report Updated: 16102018] Prices from USD $2000

Cataract Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cataract Pipeline Review, H2 2018, provides an overview of the Cataract Ophthalmology pipeline landscape.Cataract is a clouding of the normally clear lens of eye that affects vision. Symptoms include clouded, blurred or dim vision, increasing difficulty with vision at night...

Teva and New Jersey Governor Murphy Formalize North America Headquarters Move with Ceremony in Israel

Teva Pharmaceuticals announced that Teva executives Kåre Schultz and Brendan O’Grady, alongside State of New Jersey Governor, Phil Murphy, formalized Teva’s commitment to consolidate its North America Commercial business areas into New Jersey (NJ) today at the company’s global headquarters in Petach Tikva, Israel. Announced earlier this yea...

Gulf Pharmaceutical Industries PSC JULPHAR Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24072018] Prices from USD $250

SummaryGulf Pharmaceutical Industries PSC Julphar is a pharmaceutical company that manufactures and distributes medicines in the Middle East and North Africa MENA region. The company's product portfolio consists of antibiotics, antiseptics, wound care and biotechnology, women care, adult primary care, pediatric primary care, cardiopulmonary care, gastro care and pain management and consumer care p...

BCell Chronic Lymphocytic Leukemia Pipeline Review, H2 2018 [Report Updated: 14082018] Prices from USD $2000

BCell Chronic Lymphocytic Leukemia Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide BCell Chronic Lymphocytic Leukemia Pipeline Review, H2 2018, provides an overview of the BCell Chronic Lymphocytic Leukemia Oncology pipeline landscape.BCell Chronic Lymphocytic Leukemia is a type of slow growing leukemia that affects developing Bl...

Merit Medical Systems Inc MMSI Product Pipeline Analysis, 2018 Update [Report Updated: 16082018] Prices from USD $750

SummaryMerit Medical Systems, Inc. Merit Medical offers a wide range of singleuse medical devices for interventional and diagnostic procedures. The company's products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolytic catheters and fluid dispensing systems, and embolotherapeutic products. Merit Medical's products find ...

Incyte Announces Positive Interim Data from Phase 2 Trial of Pemigatinib, Its Selective FGFR Inhibitor, in Patients with Cholangiocarcinoma

Updated results presented at ESMO support planned submission of NDA in U.S. in 2019 Incyte Corporation (Nasdaq:INCY) announces updated data from its ongoing Phase 2 FIGHT-202 trial evaluating pemigatinib (INCB54828), its selective fibroblast growth factor receptor (FGFR) inhibitor, in patients with advanced/metastatic or surgically un...

Pharmaceuticals in Singapore [Report Updated: 06062018] Prices from USD $350

Pharmaceuticals in SingaporeSummaryPharmaceuticals in Singapore industry profile provides topline qualitative and quantitative summary information including: market share, market size value 201317, and forecast to 2022. The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.SynopsisEssential resource for...

Global Orthogonal Helical Gear Reducer Market Status and Outlook 20182025 [Report Updated: 13082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Neurofibromatoses Type II Pipeline Review, H2 2018 [Report Updated: 16102018] Prices from USD $2000

Neurofibromatoses Type II Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neurofibromatoses Type II Pipeline Review, H2 2018, provides an overview of the Neurofibromatoses Type II Genetic Disorders pipeline landscape.Neurofibromatosis type 2 is a disorder characterized by the growth of noncancerous tumors in the nervous system. T...

Livzon Pharmaceutical Group Inc 000513 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryLivzon Pharmaceutical Group Inc Livzon, a subsidiary of Joincare Pharmaceutical Group Industry Co Ltd, is a pharmaceutical company which is engaged in developing, manufacturing and distributing pharmaceutical products. The company provides preparation drug products, bulk medicines and intermediates, and diagnostic reagents and equipment. Its products include menotropins injection, urofollit...

Rotavirus Infections Pipeline Review, H2 2018 [Report Updated: 16102018] Prices from USD $2000

Rotavirus Infections Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rotavirus Infections Pipeline Review, H2 2018, provides an overview of the Rotavirus Infections Infectious Disease pipeline landscape.Rotavirus is a virus that infects the bowels. Rotavirus is the most common cause of severe diarrhea among infants and children. ...

Partnerships, Licensing, Investments and MA Deals and Trends for June 2018 in Pharmaceuticals [Report Updated: 31082018] Prices from USD $1000

Partnerships, Licensing, Investments and MA Deals and Trends for June 2018 in PharmaceuticalsSummaryGlobalData's Partnerships, Licensing, Investments and MA Deals and Trends for June 2018 in Pharmaceuticals report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions MAs and financings in the pharmaceuticals industry. The report provides detailed in...

Rectal Cancer Pipeline Review, H2 2018 [Report Updated: 14082018] Prices from USD $2000

Rectal Cancer Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rectal Cancer Pipeline Review, H2 2018, provides an overview of the Rectal Cancer Oncology pipeline landscape.Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The risk factors for developing rectal cancer are increasing age...

Natco Pharma Ltd NATCOPHARM Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24092018] Prices from USD $250

SummaryNatco Pharma Ltd Natco Pharma focuses on the research, development, manufacture and commercialization of pharmaceutical substances and finished dosage forms. The company offers finished dosage forms in capsule, injection and tablet. Its products are indicated to treat multiple sclerosis, influenza infection, multiple myeloma, leukemia, Crohn's disease, hypertension, Myelodysplastic syndrome...

Onyx Scientific Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24092018] Prices from USD $250

SummaryOnyx Scientific Ltd Onyx Scientific, a subsidiary of Ipca Laboratories UK Ltd is a contract research and manufacturing organization that provides chemistry services. The organization offers analytical services, chemical custom synthesis, chemical process development, continuous flow capabilities, large scale GMP API manufacturing, lead optimization services, pharmaceutical stability testing...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks